ICMR-Bharat Biotech To Fast Track COVID-19 Vaccine Trial, Plan Launch By August 15

Supported by

A letter issued by Dr Balram Bhargava, Director General, the Indian Council Of Medical Research reveals plan to launch India’s COVID-19 vaccine ‘COVAXIN’ developed in collaboration with Hyderabad-based Bharat Biotech Limited (BBIL) by August 15.

It is the first indigenous vaccine being developed by India and is one of the top priority projects, and is being monitored at the topmost level of the Government.

‘The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of virology. Pune- ICMR and BBIL are jointly working for the preclinical as well as clinical development of this vaccine,’ the letter further read.

As of now, the medical body has asked 12 institutes fasten up their clinical trials of the vaccines, to enable the subject enrollments by the first week of July.

‘You have strictly advised to fast track all approvals related to the initiation of the clinical trial and ensure that the subject enrolment is initiated no later than July 7, 2020. And non-compliance will be viewed very seriously. Therefore, advised to treat this project on the highest priority and meet the given timelines without any lapse,’ the letter read.

According to the Indian Express, the other 12 institutes include:

King George Hospital VisakhapatnamUniversity of Health Science, RohtakAIIMS Ansari, NagpurAIIMS Phulwarisharif, PatnaJeevan Rekha Hospital, Belagavi, KarnatakaGillurkar Multispeciality Hospital, NagpurRana Hospital, Rail Vihar Medical College Road, GorakhpurSRM Medical College Hospital and Research Centre, Tamil NaduNizam Institute of Medical Science. Pungutta, HyderabadDr E Venkata Rao, B 704, Palm Heights Shampur, OrissaPrakhar Hospital, Kanpur, Uttar PradeshDr Sagar Vivek Redkar, Consultant Physician, Mumbai

Last week, the pharmaceutical company had received approval from the Drug Controller General of India (DCGI) to conduct phase I and II human clinical trials.

Also Read: TikTok Parent Bytedance Looking At Whopping USD 6 Billion Loss After India’s Ban On Apps

#PoweredByYou We bring you news and stories that are worth your attention! Stories that are relevant, reliable, contextual and unbiased. If you read us, watch us, and like what we do, then show us some love! Good journalism is expensive to produce and we have come this far only with your support. Keep encouraging independent media organisations and independent journalists. We always want to remain answerable to you and not to anyone else.

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

Amplified by

P&G Shiksha

P&G Shiksha Turns 20 And These Stories Say It All

Amplified by

Isha Foundation

Sadhguru’s Meditation App ‘Miracle of Mind’ Hits 1 Million Downloads in 15 Hours, Surpassing ChatGPT’s Early Growth

Recent Stories

Denied Tree-Cutting Permit, Bihar Authorities Build ₹100 Crore Road Curving Around Trees

38 Hours After Ahmedabad Crash, Air India Boeing 777 Drops 900 Ft Post-Takeoff; DGCA Grounds Pilots, Launches Probe

Delhi Court Closes CBI Probe in JNU Student Najeeb Ahmed’s 2016 Disappearance; Mother Vows to Keep Fighting

Contributors

Writer : 
Editor : 
Creatives :